Please login to the form below

Not currently logged in
Email:
Password:

healthcare reforms

This page shows the latest healthcare reforms news and features for those working in and with pharma, biotech and healthcare.

Pharma stocks rise after Donald Trump's election win

Pharma stocks rise after Donald Trump's election win

Nevertheless, there remains much uncertainty about Trump's exact position on the industry and healthcare in general. ... In contrast Trump's plan is to repeal the Act and “bring much-needed free market reforms to the healthcare industry”.

Latest news

  • Boehringer Ingelheim returns to growth after US turnaround Boehringer Ingelheim returns to growth after US turnaround

    Chief among these were US healthcare reforms, the severe spending cuts that followed and consolidation within the US insurance industry, but the pressure appears to have eased considerably in 2015.

  • Novartis launches first biosimilar Zarxio in the US Novartis launches first biosimilar Zarxio in the US

    However, in the US, it wasn't until 2010 when Obama's healthcare reforms permitted the use of biosimilars - drugs that are bioequivalent versions of original medicines, but require some

  • Novartis biosimilar blocked by US court Novartis biosimilar blocked by US court

    In 2010, President Barack Obama's healthcare reforms allowed the use of biosimilars in the country - drugs that are bioequivalent to original medicines, but which require some R&D as they

  • Boehringer's sales drop after 'intense and challenging' year Boehringer's sales drop after 'intense and challenging' year

    US operations hit hard by healthcare reforms and insurance consolidation.  . Boehringer Ingelheim's sales fell by 5.3% to 13.3bn last year, driven down by tough operating conditions in the ... US healthcare reforms, the severe spending cuts that

  • FDA approves first biosimilar FDA approves first biosimilar

    In 2010 US President Barack Obama introduced new healthcare reforms that allowed biosimilars onto the market, but it has proved a difficult path for the regulator, which had no reference points ... Express Scripts estimates that the US healthcare system

More from news
Approximately 2 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    Why personalised medicine based on our own genomes is the future of healthcare. ... Most importantly, we have still been fortunate enough to witness medical and scientific breakthroughs, helping families marked by devastating diseases to find new hope

  • Risks, reforms and rewards: the evolving Russian healthcare market Risks, reforms and rewards: the evolving Russian healthcare market

    The Russian healthcare sector is still shaped by the legacy of the Soviet Union and the decade of economic turmoil that followed.While reforms introduced in the past two decades have ... The financing reforms coincided with a decade of economic

  • Adding value to company leadership Adding value to company leadership

    Primarily, change is needed in response to global healthcare reforms requiring companies to demonstrate how their products improve patient outcomes, lower costs or both. ... innovative thinkers at its helm, the healthcare industry will be better able to

  • US health reforms US health reforms

    Is the stage set for price controls in the US? Most stakeholders in the US healthcare marketplace would prefer to see the Affordable Care Act survive ongoing efforts at repeal and ... Even so, the idea of repeal and replace as an actual attempt to

  • Drivers for change – payer value perceptions Drivers for change – payer value perceptions

    In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers. ... Broad-based healthcare reforms, new pricing regulations, increasing tendering processes and emphasis on

More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest appointments

  • McCann Health Americas names president McCann Health Americas names president

    McCann Worldgroup is expanding these regional operations in response to changes in the consumer and healthcare communications environment, in part related to healthcare insurance reforms in the US. ... The expansion includes an extensive investment

  • Former Blair adviser to lead NHS England Former Blair adviser to lead NHS England

    In this role, he has handled directly the impact of President Obama's healthcare reforms, heading up the company's reform implementation and care innovation plans, which include developing new models ... This extensive career in healthcare was commended

  • Healthwatch England appoints comms and policy directors Healthwatch England appoints comms and policy directors

    They join a senior team headed by Dr Katherine Rake, who was appointed chief executive in December 2012, shortly after the body was formed as part of major reforms to the ... Both new appointments have experience across the UK healthcare industry, with

  • Jeremy Hunt replaces Andrew Lansley as UK Health Secretary

    for BSkyB, and he will have a challenge on his hands to gain public support for his predecessor's much criticised healthcare reforms. ... Stephen Whitehead, CEO of the Association of the British Pharmaceutical Industry (ABPI), also commented on Hunt's

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....